SIGLEC9 anticorps (C-Term)
Aperçu rapide pour SIGLEC9 anticorps (C-Term) (ABIN634755)
Antigène
Voir toutes SIGLEC9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- SIGLEC9 antibody was raised against the C terminal of SIGLEC9
-
Purification
- Affinity purified
-
Immunogène
- SIGLEC9 antibody was raised using the C terminal of SIGLEC9 corresponding to a region with amino acids PWVHLRDAAEFTCRAQNPLGSQQVYLNVSLQSKATSGVTQGVVGGAGATA
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SIGLEC9 Blocking Peptide, (ABIN5616146), is also available for use as a blocking control in assays to test for specificity of this SIGLEC9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SIGLEC9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SIGLEC9 (Sialic Acid Binding Ig-Like Lectin 9 (SIGLEC9))
-
Autre désignation
- SIGLEC9
-
Sujet
- SIGLEC9 is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. It preferentially binds to alpha2,3- or 2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.
-
Poids moléculaire
- 50 kDa (MW of target protein)
Antigène
-